Citadel Advisors »

Enveric Biosciences shares owned by Citadel Advisors

Quarter-by-quarter ownership of Enveric Biosciences (ENVB) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Enveric Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Enveric Biosciences held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enveric Biosciences by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $15k 23k 0.64
2025-03-31 $28k 20k 1.39

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Enveric Biosciences

AdvisorShares Investments
UBS Group
Geode Capital Management
Citadel Advisors
Morgan Stanley
Tower Research Capital
BlackRock
SBI Securities
National Bank Of Canada /fi/
Wells Fargo & Company
Group One Trading

View all funds holding Enveric Biosciences